Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer

Kidney-type glutaminase (GLS) and liver-type glutaminase (GLS2) are dysregulated in many cancers, making them appealing targets for cancer therapy. However, their use as prognostic biomarkers is controversial and remains an active area of cancer research. Here, we performed a systematic multiomic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Subbroto Kumar, Islam, S.M. Riazul, Abdullah-AL-Wadud, M., Islam, Saiful, Ali, Farman, Park, Kyoung Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463114/
https://www.ncbi.nlm.nih.gov/pubmed/30871151
http://dx.doi.org/10.3390/jcm8030355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463114/
https://www.ncbi.nlm.nih.gov/pubmed/30871151
http://dx.doi.org/10.3390/jcm8030355

Ejemplares similares